Thomas Reiser/LinkedIn
Dec 11, 2025, 23:36
Register for the ISTH Andexanet Research Recap
Thomas Reiser, Executive Director of the International Society on Thrombosis and Haemostasis (ISTH), posted on LinkedIn:
”How do researchers evaluate the effects of andexanet in healthy volunteers and patients with acute major bleeding on enoxaparin?
Register for the upcoming International Society on Thrombosis and Haemostasis (ISTH) RPTH Journal Research Recap on
December 18 (17:00 UTC) with author Thijs van Haaps and Moderator Lara Roberts.”
Stay updated with Hemostasis Today.
-
Oct 10, 2026, 17:58Archo Farzana Batool: Exploring Medical Writing Through an Article on Iron Deficiency Anemia
-
Oct 10, 2026, 17:53Assessing Frailty in Adults With Hemophilia – JTH
-
Oct 10, 2026, 17:52Fatma Sadeghi: Reducing Maternal Health Inequalities Through Nursing Advocacy
-
Oct 10, 2026, 17:50Grzegorz Hensler: How Apheresis Transformed Blood Cell Separation and Collection
-
Oct 10, 2026, 17:47Hemant K Sharma: Japan’s Universal Artificial Blood Research – A Potential Breakthrough in Transfusion Medicine
-
Oct 10, 2026, 17:40John Strouse: Learning About Bleeding Disorders and Sickle Cell Disease at FWGBD
-
Oct 10, 2026, 17:34Mae Caime: Speaking at the Annual Women’s Retreat for the Hemophilia Community in Florida
-
Oct 10, 2026, 17:30Chokri Ben Lamine: PNH beyond the Textbook Triad
-
Oct 10, 2026, 17:29Ruah Alyamany: Thrombosis and Anticoagulation in Hematological Malignancies at SOHO KSA 2026